Pharmaceutical Serialization Mandates Expand Worldwide Fast
The United States Drug Supply Chain Security Act and the European Union Falsified Medicines Directive established unit-level pharmaceutical serialization as a legal requirement across two of the world's largest drug markets, and a growing list of additional countries, including India, Brazil, and several Gulf states, have since introduced comparable requirements. Each new mandate requires pharmaceutical manufacturers and packaging converters to integrate serialized data capture directly into production lines, a capital investment that has driven substantial demand for track-and-trace equipment and services. Generic drug manufacturers, particularly those based in India serving export markets, face mounting pressure to comply quickly given the country's role as a major global generic drug supplier.
Market Impact: Affects roughly 10% of medicines








